In addition, in our study, APOE ε4 was found to be associated with increased risk of incident AD in univariate analysis (p = .045) but not in multivariate analysis adjusting for age and gender (p = .077), compared to the APOE ε4 non-carriers (Supplementary Table S3). Here, APOE is linked to Alzheimer disease.